Delivery Order SPE2DR25D1053-SPE2DR26FU656
- Not listed
- The Defense Logistics Agency awarded a $2,045.53 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Premarin 0.3 mg tablets (100-unit quantity). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 22, 2025. The contract is performed out of AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $1,154.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100-count units) on December 10, 2025, with completion expected by December 11, 2025. This non-set-aside contract represents a competitive procurement action that leverages AmerisourceBergen's existing pharmaceutical supply capabilities within the federal medical supply chain. The delivery location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 1.25 mg tablets (100 count) under a firm fixed-price contract valued at $3,837.72. The award was made on December 9, 2025, with an ultimate completion date of December 10, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Premarin 0.3 mg tablets (100-count units) with a ceiling value of $3,573.18 and a firm fixed price structure. This delivery order is not set-aside and was competitively awarded, with an ultimate completion date of June 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,014.80 to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100 count) on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, which serves as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,418.55 to AmerisourceBergen Drug Corp for the supply of Premarin 0.9 mg tablets (100-count units) on December 1, 2025, with an ultimate completion date of December 2, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Premarin 0.3 mg tablets (100-count units) under a firm fixed-price contract valued at $1,766.95. The order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing pharmaceutical supply agreement. The contractor, headquartered in Conshohocken, Pennsylvania, will perform under this order at its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Premarin 0.3 mg tablets in quantities of 100, with a contract ceiling value of $3,740.12 and a firm fixed price structure. This delivery order represents a non-set-aside competitive award and is scheduled for ultimate completion by September 29, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100-count units) under a firm fixed-price contract valued at $3,523.85. The award was made on June 3, 2025, with an ultimate completion date of June 4, 2025, and utilizes no set-aside designation, indicating the contract was competitively awarded. Performance will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, the company's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg with a firm fixed price ceiling value of $1,593.95. This non-set-aside competitive award, issued on November 24, 2025, represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical supplier for...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FU656Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Premarin 0.3 mg tablets in quantities of 100 units, valued at $2,935.22. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by December 12, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military and federal healthcare systems. The company's federal contract awards span diverse therapeutic areas including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialty medical commodities, positioning it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/10/25 |